Drug intelligence / Profile preview

1% metformin gel

Development stage
Unknown
Lead developer
Government Dental College and Research Institute
Modality
Small Molecules, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

1% metformin gel is a locally-delivered, biodegradable, controlled-release formulation developed by researchers at the Government Dental College and Research Institute in Bangalore, India. While metformin is traditionally an oral biguanide used for type 2 diabetes, this specific formulation is designed for subgingival application as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis and intrabony periodontal defects. The drug exerts its therapeutic effect by promoting osteoblast proliferation and differentiation, leading to bone-sparing effects and the regeneration of alveolar bone within periodontal pockets. Clinical trials have demonstrated significant improvements in clinical parameters such as probing depth reduction, clinical attachment level gain, and bone defect fill compared to scaling and root planing alone.

Other names
1% MF gellocally delivered metformin gelmetformin gel
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)BMP2 (Bone morphogenetic protein 2)

Beyond the preview

Go deeper on 1% metformin gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1% metformin gel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call